Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Preparation of Blatter Radicals via Aza-Wittig Chemistry: The Reaction of N-Aryliminophosphoranes with 1-(Het)aroyl-2-aryldiazenes.

Savva AC, Mirallai SI, Zissimou GA, Berezin AA, Demetriades M, Kourtellaris A, Constantinides CP, Nicolaides C, Trypiniotis T, Koutentis PA.

J Org Chem. 2017 Jul 21;82(14):7564-7575. doi: 10.1021/acs.joc.7b01297. Epub 2017 Jun 29.

PMID:
28628743
2.

Exercise contagion in a global social network.

Aral S, Nicolaides C.

Nat Commun. 2017 Apr 18;8:14753. doi: 10.1038/ncomms14753.

3.

Self-organization of network dynamics into local quantized states.

Nicolaides C, Juanes R, Cueto-Felgueroso L.

Sci Rep. 2016 Feb 17;6:21360. doi: 10.1038/srep21360.

4.

The price of anarchy in mobility-driven contagion dynamics.

Nicolaides C, Cueto-Felgueroso L, Juanes R.

J R Soc Interface. 2013 Jul 31;10(87):20130495. doi: 10.1098/rsif.2013.0495. Print 2013 Oct 6.

5.

Short- and long-range binding of Be with Mg in the X1Σ+ ground state and in the A1Π excited state.

Kerkines IS, Nicolaides CA.

J Chem Phys. 2012 Sep 28;137(12):124309.

PMID:
23020333
6.

A metric of influential spreading during contagion dynamics through the air transportation network.

Nicolaides C, Cueto-Felgueroso L, González MC, Juanes R.

PLoS One. 2012;7(7):e40961. doi: 10.1371/journal.pone.0040961. Epub 2012 Jul 19.

7.

Anomalous physical transport in complex networks.

Nicolaides C, Cueto-Felgueroso L, Juanes R.

Phys Rev E Stat Nonlin Soft Matter Phys. 2010 Nov;82(5 Pt 2):055101. Epub 2010 Nov 10.

PMID:
21230532
8.

Delay in photoemission.

Schultze M, Fiess M, Karpowicz N, Gagnon J, Korbman M, Hofstetter M, Neppl S, Cavalieri AL, Komninos Y, Mercouris T, Nicolaides CA, Pazourek R, Nagele S, Feist J, Burgdörfer J, Azzeer AM, Ernstorfer R, Kienberger R, Kleineberg U, Goulielmakis E, Krausz F, Yakovlev VS.

Science. 2010 Jun 25;328(5986):1658-62. doi: 10.1126/science.1189401.

9.

Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group.

Kosmidis PA, Kalofonos HP, Christodoulou C, Syrigos K, Makatsoris T, Skarlos D, Bakogiannis C, Nicolaides C, Bafaloukos D, Bamias A, Samantas E, Xiros N, Boukovinas I, Fountzilas G, Dimopoulos MA.

Ann Oncol. 2008 Jan;19(1):115-22. Epub 2007 Oct 15.

PMID:
17938425
10.

Gemcitabine versus gemcitabine-carboplatin for patients with advanced non-small cell lung cancer and a performance status of 2: a prospective randomized phase II study of the Hellenic Cooperative Oncology Group.

Kosmidis PA, Dimopoulos MA, Syrigos K, Nicolaides C, Aravantinos G, Boukovinas I, Pectasides D, Fountzilas G, Bafaloukos D, Bacoyiannis C, Kalofonos HP.

J Thorac Oncol. 2007 Feb;2(2):135-40.

13.

Rituximab in combination with CNOP chemotherapy in patients with previously untreated indolent non-Hodgkin's lymphoma.

Economopoulos T, Fountzilas G, Pavlidis N, Kalantzis D, Papageorgiou E, Christodoulou C, Hamilos G, Nicolaides C, Dimopoulos M.

Hematol J. 2003;4(2):110-5.

PMID:
12750729
14.

Vinblastine and interferon-gamma combination with and without 13-cis retinoic acid for patients with advanced renal cell carcinoma. Results of two phase II clinical trials.

Bacoyiannis C, Dimopoulos MA, Kalofonos HP, Nicolaides C, Aravantinos G, Bafaloukos D, Samelis G, Onyenadum A, Kiamouris Ch, Skarlos D, Pavlidis N, Triantafillidis A, Kosmidis P; Hellenic Cooperative Oncology Group.

Oncology. 2002;63(2):130-8.

PMID:
12239447
15.

Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial.

Kosmidis P, Mylonakis N, Nicolaides C, Kalophonos C, Samantas E, Boukovinas J, Fountzilas G, Skarlos D, Economopoulos T, Tsavdaridis D, Papakostas P, Bacoyiannis C, Dimopoulos M.

J Clin Oncol. 2002 Sep 1;20(17):3578-85.

PMID:
12202657
16.

Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP.

Economopoulos T, Dimopoulos MA, Mellou S, Pavlidis N, Samantas E, Nicolaides C, Tsatalas C, Papadopoulos A, Papageogriou E, Papasavvas P, Fountzilas G.

Eur J Haematol. 2002 Mar;68(3):135-43.

PMID:
12068793
17.

Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?

Liberopoulos E, Karabina SA, Tselepis A, Bairaktari E, Nicolaides C, Pavlidis N, Elisaf M.

Oncology. 2002;62(2):115-20.

PMID:
11914596
18.

Primary treatment of low-grade non-Hodgkin's lymphoma with the combination of fludarabine and mitoxantrone: a phase II study of the Hellenic Cooperative Oncology Group.

Dimopoulos MA, Fountzilas G, Papageorgiou E, Kiamouris C, Mantzios G, Anagnostopoulos A, Nicolaides C, Economopoulos T; Hellenic Cooperative Oncology Group.

Leuk Lymphoma. 2002 Jan;43(1):111-4.

PMID:
11908713
19.

A phase III study of 5-fluorouracil versus 5-fluorouracil plus interferon alpha 2b versus 5-fluorouracil plus leucovorin in patients with advanced colorectal cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.

Kalofonos HP, Nicolaides C, Samantas E, Mylonakis N, Aravantinos G, Dimopoulos MA, Gennatas C, Kouvatseas G, Giannoulis E, Dervenis C, Basdanis G, Pavlidis N, Androulakis I, Fountzilas G; Hellenic Cooperative Oncology Group (HeCOG).

Am J Clin Oncol. 2002 Feb;25(1):23-30.

PMID:
11823690
20.

Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group.

Pectasides D, Aravantinos G, Kalofonos H, Kiamouris C, Bafaloukos D, Xiros N, Nicolaides C, Visvikis A, Dimopoulos MA.

Ann Oncol. 2001 Oct;12(10):1417-22.

PMID:
11762814
21.

Nonhyperbolic escape and changes in phase-space stability structures in laser-induced multiphoton dissociation of a diatomic molecule.

Constantoudis V, Nicolaides CA.

Phys Rev E Stat Nonlin Soft Matter Phys. 2001 Nov;64(5 Pt 2):056211. Epub 2001 Oct 22.

PMID:
11736058
22.

An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group.

Pectasides D, Kalofonos HP, Samantas E, Nicolaides C, Papacostas P, Onyenadum A, Visvikis A, Skarlos D, Fountzilas G.

Anticancer Res. 2001 Jul-Aug;21(4B):3005-10.

PMID:
11712802
23.

Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas.

Bai M, Vlachonikolis J, Agnantis NJ, Tsanou E, Dimou S, Nicolaides C, Stefanaki S, Pavlidis N, Kanavaros P.

Mod Pathol. 2001 Nov;14(11):1105-13. Erratum in: Mod Pathol 2002 Apr;15(4):475. Kanavarous P [corrected to Kanavaros P].

24.

Effect of letrozole on the lipid profile in postmenopausal women with breast cancer.

Elisaf MS, Bairaktari ET, Nicolaides C, Kakaidi B, Tzallas CS, Katsaraki A, Pavlidis NA.

Eur J Cancer. 2001 Aug;37(12):1510-3.

PMID:
11506958
25.

Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer.

Fountzilas G, Papadimitriou C, Aravantinos G, Nicolaides C, Stathopoulos G, Bafaloukos D, Kalofonos H, Ekonomopoulos T, Skarlos D, Pavlidis N, Dimopoulos AM.

Oncology. 2001;60(3):214-20.

PMID:
11340372
26.

Phase II study of pegylated liposomal doxorubicin: inactive in recurrent small-cell lung cancer. A Hellenic Cooperative Oncology Group Study.

Samantas E, Kalofonos H, Linardou H, Nicolaides C, Mylonakis N, Fountzilas G, Kosmidis P, Skarlos D.

Ann Oncol. 2000 Nov;11(11):1395-7.

PMID:
11142478
27.

Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic Cooperative Oncology Group.

Nicolaides C, Dimopoulos MA, Samantas E, Bafaloukos D, Kalofonos C, Fountzilas G, Razi E, Kosmidis P, Pavlidis N.

Ann Oncol. 2000 Jul;11(7):873-5.

PMID:
10997817
28.

Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: a Hellenic Cooperative Oncology Group Phase II study.

Fountzilas G, Nicolaides C, Bafaloukos D, Kalogera-Fountzila A, Kalofonos H, Samelis G, Aravantinos G, Pavlidis N.

Cancer Invest. 2000;18(6):503-9.

PMID:
10923097
29.

Prognostic Factors in Aggressive Non-Hodgkin's Lymphomas.

Nicolaides C, Dimou S, Pavlidisa N.

Oncologist. 1998;3(3):189-197.

30.

Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group.

Fountzilas G, Stathopoulos G, Nicolaides C, Kalogera-Fountzila A, Kalofonos H, Nikolaou A, Bacoyiannis C, Samantas E, Papadimitriou C, Kosmidis P, Daniilidis J, Pavlidis N.

Ann Oncol. 1999 Apr;10(4):475-8.

PMID:
10370793
31.

First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): a phase II study conducted by the Hellenic Cooperative Oncology Group.

Fountzilas G, Dimopoulos AM, Papadimitriou C, Kalogera-Fountzila A, Aravantinos G, Bafaloukos D, Athanassiades A, Nicolaides C, Keramopoulos A, Pavlidis N, Kosmidis P, Skarlos D.

Ann Oncol. 1998 Sep;9(9):1031-4.

PMID:
9818080
32.

Dose-dense adjuvant chemotherapy with epirubicin monotherapy in patients with operable breast cancer and >/=10 positive axillary lymph nodes. A feasibility study.

Fountzilas G, Nicolaides C, Aravantinos G, Skarlos D, Kosmidis P, Papakostas P, Stathopoulos GP, Kontostolis E, Bafaloukos D, Pavlidis N.

Oncology. 1998 Nov-Dec;55(6):508-12.

PMID:
9778614
33.

Diffuse large cell lymphomas: identification of prognostic factors and validation of the International Non-Hodgkin's Lymphoma Prognostic Index. A Hellenic Cooperative Oncology Group Study.

Nicolaides C, Fountzilas G, Zoumbos N, Skarlos D, Kosmidis P, Pectasides D, Karabelis A, Giannakakis T, Symeonidis A, Papadopoulos A, Antoniou F, Pavlidis N.

Oncology. 1998 Sep-Oct;55(5):405-15.

PMID:
9732217
34.

Bcl2 and p53 protein expression in metastatic carcinoma of unknown primary origin: biological and clinical implications. A Hellenic Co-operative Oncology Group study.

Briasoulis E, Tsokos M, Fountzilas G, Bafaloukos D, Kosmidis P, Samantas E, Skarlos D, Nicolaides C, Pavlidis N.

Anticancer Res. 1998 May-Jun;18(3B):1907-14.

PMID:
9677443
35.

Tropisetron in the prevention of acute nausea and vomiting in patients treated with high dose epirubicin.

Nicolaides C, Giannakakis T, Skarlos D, Athanassiadis A, Fountzilas G, Damigos D, Pavlidis N.

J Exp Clin Cancer Res. 1998 Mar;17(1):71-5.

PMID:
9646236
36.

Paclitaxel and carboplatin as first-line chemotherapy for advanced breast cancer.

Fountzilas G, Athanassiades A, Papadimitriou V, Dimopoulos MA, Bafaloukos D, Aravantinos G, Nicolaides C, Kalofonos H, Papakostas P, Xiros N, Razi E.

Oncology (Williston Park). 1998 Jan;12(1 Suppl 1):45-8.

37.

Intensified carboplatin regimen with GM-CSF support in non-small cell lung cancer (NSCLC). A Hellenic Co-operative Oncology Group Study (HeCOG).

Nicolaides C, Klouvas G, Fountzilas G, Athanassiadis A, Skarlos D, Samantas E, Kosmidis P, Mylonakis N, Pavlidis N.

J Exp Clin Cancer Res. 1997 Mar;16(1):91-4.

PMID:
9148868
38.

Clinical value of CA 15-3, mucin-like carcinoma-associated antigen, tumor polypeptide antigen, and carcinoembryonic antigen in monitoring early breast cancer patients.

Pectasides D, Pavlidis N, Gogou L, Antoniou F, Nicolaides C, Tsikalakis D.

Am J Clin Oncol. 1996 Oct;19(5):459-64.

PMID:
8823487
39.

The beneficial effect of tamoxifen on serum lipoprotein-A levels: an additional anti-atherogenic property.

Elisaf M, Bairaktari E, Nicolaides C, Fountzilas G, Tzallas C, Siamopoulos K, Tsolas O, Pavlidis N.

Anticancer Res. 1996 Sep-Oct;16(5A):2725-8.

PMID:
8917378
40.

Phase II study of 5-fluorouracil and interferon-gamma in patients with metastatic colorectal cancer. A Hellenic Cooperative Oncology Group Study.

Pavlidis N, Nicolaides C, Athanassiadis A, Beriatou K, Skarlos D, Giannakakis T, Kosmidis P, Karvounis N, Fountzilas G.

Oncology. 1996 Mar-Apr;53(2):159-62.

PMID:
8604243
41.

Soluble interleukin-2 receptors in patients with advanced colorectal carcinoma.

Pavlidis N, Nicolaides C, Bairaktari E, Kalef-Ezra J, Athanassiadis A, Seferiadis C, Fountzilas G.

Int J Biol Markers. 1996 Jan-Mar;11(1):6-11.

PMID:
8740635
42.

Determination of dipole polarizabilities for Mg+ and Ca+ ions from precision lifetime measurements and transition-moment cancellations.

Theodosiou CE, Curtis LJ, Nicolaides CA.

Phys Rev A. 1995 Nov;52(5):3677-3680. No abstract available.

PMID:
9912670
43.

Dipole polarizabilities and hyperpolarizabilities of excited valence states of Be.

Themelis SI, Nicolaides CA.

Phys Rev A. 1995 Sep;52(3):2439-2441. No abstract available.

PMID:
9912507
44.

Asymmetry parameter and total cross section for the photodetachment of the metastable Be- 1s22s2p24P state.

Sinanis C, Komninos Y, Nicolaides CA.

Phys Rev A. 1995 Apr;51(4):R2672-R2675. No abstract available.

PMID:
9911992
45.

High-order harmonic generation and above-threshold ionization in H: Calculations using expansions over field-free state-specific wave functions.

Dionissopoulou S, Mercouris T, Lyras A, Komninos Y, Nicolaides CA.

Phys Rev A. 1995 Apr;51(4):3104-3111. No abstract available.

PMID:
9911947
46.

Field-induced tunneling rates, polarizabilities, and hyperpolarizabilities for low-lying excited states of Li and Na.

Themelis SI, Nicolaides CA.

Phys Rev A. 1995 Apr;51(4):2801-2807. No abstract available.

PMID:
9911911
47.

Serum soluble interleukin-2 receptors in epithelial ovarian cancer patients.

Pavlidis NA, Bairaktari E, Kalef-Ezra J, Nicolaides C, Seferiadis C, Fountzilas G.

Int J Biol Markers. 1995 Apr-Jun;10(2):75-80.

PMID:
7561242
48.

Energies and widths of triply excited n=2 intrashell autoionizing states of He-

Bylicki M, Nicolaides CA.

Phys Rev A. 1995 Jan;51(1):204-210. No abstract available.

PMID:
9911574
49.
50.

Computation of strong-field multiphoton processes in polyelectronic atoms: State-specific method and applications to H and Li-

Mercouris T, Komninos Y, Dionissopoulou S, Nicolaides CA.

Phys Rev A. 1994 Nov;50(5):4109-4121. No abstract available.

PMID:
9911385

Supplemental Content

Loading ...
Support Center